Staphyt

Staphyt provides field trials, laboratory studies, and regulatory consulting services to support the development and market entry of agricultural products including plant protection products, biopesticides, biostimulants, fertilizers, seeds, chemicals/biocides as well as some pharmaceutical sector support. The company specializes in efficacy testing under controlled conditions and in the field for both chemical and biological products. It also offers comprehensive regulatory strategy consulting to help clients navigate complex approval processes across multiple regions.

Staphyt does not have its own clinical pipeline but supports client R&D with trial design/execution and regulatory submissions.

In 2023 it reported €45.5 million turnover with over 600 employees operating in more than 15 countries across three continents.

Its BioTeam division focuses on biopesticide/biostimulant research including screening substances for efficacy/resistance/tolerance under various environmental conditions.

The company has expanded through organic growth as well as acquisitions of regional CROs/laboratories/regulatory consultancies in Europe and Latin America.